„Bulking Agents” zur Behandlung der männlichen und weiblichen Stressinkontinenz - Eine Standortbestimmung

Zusammenfassung

Die submuköse Injektion von Substanzen zur Einengung des Urethralumens und Verbesserung einer Stressinkontinenz wird seit 1918 durchgeführt. Während anfänglich die Einengung durch narbige Veränderungen als Folge der Injektion von z. B. Paraffin erfolgte, wurde später die Einengung durch Ausbildung eines submukösen Polsters angestrebt. Als erstes „Bulking Agent” wurde Polytetrafluoroethylen (Teflon®) eingesetzt [4]. Die Langzeitresultate mit einer Erfolgsrate von 13 - 38 % bei der Stressinkontinenz der Frau sowie 23 - 80 % beim Mann sind jedoch enttäuschend. Die Migration der Partikel durch Phagozytose und Transport (z. B. in Haut, Lunge) hat dazu geführt, dass andere Substanzen erprobt wurden: autologes Fett, Kollagen und Silikon. Der Effektverlust durch den Abbau von Kollagen und Fett konnte durch den Einsatz von Silikon überwunden werden. Dennoch haben alle diese Substanzen nicht zu zufrieden stellenden Langzeitresultaten geführt. Gute Kurzzeiterfolge durch den Einsatz von Silikon bei der postoperativen Stressinkontinenz des Mannes werden beschrieben. Neuere Substanzen befinden sich in der klinischen Erprobung. Derzeit ist die Therapie mit „Bulking Agents” bei der Frau eine Option bei Hochrisiko-Patientinnen, die einer konventionellen operativen Therapie nicht zuzuführen sind. Bei Patientinnen, die operative Verfahren ablehnen oder aber bei der persistierenden Stressinkontinenz aufgrund einer intrinsischen Sphinkterinsuffizienz z. B. nach frustraner konventioneller operativer Therapie kann der Einsatz von „Bulking Agents” erwogen werden. Anatomische Veränderungen wie z. B. eine Zystozele können nicht korrigiert werden. Bei der postoperativen Sphinkterschwäche des Mannes kann die Unterspritzung zu einer Besserung der Frühkontinenz führen. Die Therapie mit „Bulking Agents” kann komplikations- und schmerzarm durchgeführt werden und führt bei einem eng umschriebenen Patientengut zu guten Ergebnissen.

Abstract

Injection therapy for the treatment of stress urinary incontinence has been in use since 1918. In the early years, narrowing of the urethral lumen was achieved by injection of substances like paraffin that resulted in scarring of the urethra. Later, bulking agents were developed, that formed a submucosal cushion in the urethra. The first substance used for this purpose was polytetrafluoroethylene (Teflon®), reported by Berg in 1973. The initially good results were soon followed by disappointing long-term results with success rates of 13 - 38 % in the treatment of females and 23 - 80 % in the treatment of males. Migration of Teflon®-particles (e. g. to the lung or brain) due to phagocytosis occurred and led to severe complications. Therefore other bulking agents, such as autologous fat, collagen and silicone, were tested. The quick degradation of fat and collagen could be overcome by the use of silicone, which remains at the injecition site due to its particle size. Nevertheless, none of these substances have led to sufficient long term results, although short-term success rates of 100 % in the treatment of male incontinence have been reported. A wide variety of new substances are currently being tested in animal experiments and clinical studies. At present, treatment with bulking agents should be restricted to female high-risk-patients unable to undergo conventional operative procedures. It should be considered for females who reject conventional treatment or have an intrinsic sphincteric deficiency in whom such procedures have failed. Anatomic pathologies like cystoceles cannot be cured. Only males with reduced sphincteric function (e. g. isolated lesion of the external sphincter) after operative treatment of the prostate may benefit from transurethral injection therapy. Patients with complete destruction of the external sphincter will not have any benefit over a longer period of time. Therefore only careful patient selection can achieve good results in the use of bulking agents.

Inkontinenz - Kollagen - Silikon - Autologes Fett - Bulking Agents

Incontinence - Collagen - Silicone - Autologous fat - Bulking agents

Literatur

• 1 Murless B. The injection treatment of stress urinary incontinence.  J Obstet Gynaecol Br Emp. 1938;  45 67
• 2 Palmtag H, Goepel M. Welchen Wert haben periurethrale Injektionen bei weiblicher Stressinkontinenz?.  Urol A. 2000;  40 444-445
• 3 Stenzel A, Strasser H. Submucosal bladder neck injections for management of stress urinary incontinence.  Braz J Urol. 2000;  26 199-207
• 4 Berg S. Polytef augmentation urethroplasty. Correction of surgically incurable incontinence by injection technique.  Arch Surg. 1973;  107 379-381
• 5 Gonzales Garibay S, Jimeno C, York M, Gomez P, Borruell S. Auto Transplantation endoscopique de tissu graisseur dans le traitement de l'incontinence urinaire chez la femme.  (Endoscopic autotransplantation of fat tissue in the treatment of urinary incontinence in the female) J Urol Paris. 1989;  95 363-366
• 6 Shortliffe L M, Freiha F S, Kessler R, Stamey T A, Constantinou C E. Treatment of urinary incontinence by the periurethral implantation of glutaraldehyde cross-linked collagen.  J Urol. 1989;  141 538-541
• 7 Harris D R, Iacovou J W, Lemberger R J. Periurethral silicone microimplants (Macroplastique) for the treatment of genuine stress incontinence.  Br J Urol. 1996;  78 722-725
• 8 Dmochowski R R, Appell R A. Injectable agents in the treatment of stress urinary incontinence in women: where are we now?.  Urology. 2000;  56 32-40
• 9 Buckley J F, Lingham K, Meddings R N, Scott R. Injectable Teflon paste for female stress incontinence: long term follow-up and results.  J Urol. 1994;  151 418A (abstract 764)
• 10 Beckingham U, Wemyss-Holden G, Lawence W T. Long term follow-up of women treated with periurethral Teflon injections for stress incontinence.  Br J Urol. 1992;  69 580-583
• 11 Lopez A E, Padron O F, Patsiasis G, Politano V A. Transurethral polytetrafluoroethylene injection in female patients with urinary incontinence.  J Urol. 1993;  150 856-858
• 12 Harrison S C, Brown C, O`Boyle P J. Periurethral teflon for stress urinary incontinence: medium term results.  Br J Urol. 1993;  71 25-27
• 13 Kiilholma J, Makinen J. Disappointing effect of endoscopic teflon injection for female stress incontinence.  Eur Urol. 1991;  20 197-199
• 14 Vincente Rodriguez J. Résultants tardifs de l`injection endouretrale de Téflon dans l'`incontinence urinaire a l'¿effort. (Late results of the endourethral injection of Teflon in urinary stress incontinence).  J Urol Paris. 1987;  93 537-539
• 15 Politano V A. Transurethral polytef injection for post-prostatectomy urinary incontinence.  Br J Urol. 1992;  69 26-28
• 16 Kaballin J N. Treatment of post-prostatectomy stress urinary incontinence with periurethral polytetrafluoroethylene paste injection.  J Urol. 1994;  152 1463-1466
• 17 Oster P J, Rohl H F. Teflon injection in post-prostatectomy incontinence.  Scand J Urol Nephrol. 1988;  22 171-174
• 18 Stanisic T H, Jennings C E, Miller J I. Polytetrafuoroethylene injection for post-prostatectomy incontinence: experience with 20 patients during 3 years.  J Urol. 1991;  146 1575-1577
• 19 Borgatti R, Tettamanti A, Piccinelli P. Brain injury in a healthy child one year after periurethral injection.  Pediatrics. 1996;  98 290-291
• 20 Claes H, Stroobants D, Van Meerbeek J, Verbeken E, Knockaert D, Baert L. Pulmonary migration following periurethral polytetrafluoroethylene injection for urinary incontinence.  J Urol. 1989;  142 821-822
• 21 Kiilholma J P, Chancellor B M, Makinen J, Hirsch H I, Klemi J P. Complication of teflon injection for stress urinary incontinence.  Neurourol Urodynam. 1993;  12 131
• 22 Malizia jr A A, Reiman H M, Myres R P, Sande J R, Barham S S, Benson jr R C, Dewanjee M K, Utz W J. Migration and granulomatous reaction after periurethral injection of Polytef (Teflon).  JAMA. 1984;  251 3277
• 24 Ferro M A, Smith J H, Smith P J. Periurethral granuloma: unusual complication of Teflon periurethral injection.  Urology. 1988;  31 422-423
• 25 Mc Kinney C D, Gaffey M J, Gillenwater J Y. Bladder outlet obstruction after multiple periurethral polytetrafluoroethylene injections.  J Urol. 1995;  153 149-151
• 26 Dewan P A. Is injected Polytetrafluoroethylene (Polytef) carcinogenic?.  Br J Urol. 1992;  69 29-33
• 27 Hakky M, Kolbusz R, Reyes C V. Chondrosarcoma of the larynx.  ENT J. 1989;  68 60-62
• 28 Simonato A, Galli S, Romagnoli A, Carmignani G. Urinary incontinence after radical prostatectomy: severe ultrasonography changes following periurethral injection of polytetrafluoroethylene.  Arch Ital Urol Androl. 1999;  71 271-274
• 29 Blaivas J G, Heritz D, Santarosa P R, Dmochowski R, Ganabathi K, Roskamp D, Leach G. Periurethral fat injection for sphincteric incontinence in women.  J Urol. 1994;  151 419A (abstract 765)
• 30 Cervigni M, Tomiselli G, Pericone G, Panei M. Il trattamento endoscopico dell'¿insuficenza sfinterica mediante l¿infiltratione con grasso autologo (Endoscopic treatment of sphincter insufficiency with autologous fat injection).  Arch Ital Urol Androl. 1994;  66 219-224
• 31 Haab F, Zimmern P, Leach G. Urinary stress incontinence due to intrinsic sphincteric deficiency: experience with fat and collagen periurethral injections.  J Urol. 1997;  157 1283-1286
• 32 Lee P E, Kung R C, Drutz H P. Periurethral autologous fat injection as treatment for female stress urinary incontinence: A randomized double-blind controlled trial.  J Urol. 2001;  165 153-158
• 33 Palma P C, Ricetto C L, Herrmann V, Netto jr N R. Repeated lipoinjections for stress urinary incontinence.  J Endourol. 1997;  11 67-70
• 34 Santarosa R P, Blaivas J G. Periurethral injection of autologous fat for the treatment of sphincteric incontinence.  J Urol. 1994;  151 607-611
• 35 Su T H, Wang K G, Hsu C Y, Wie H J, Yen H J, Shien F C. Periurethral fat injection in the treatment of recurrent genuine stress incontinence.  J Urol. 1998;  159 411-414
• 36 Ishizaka K, Koga H, Kamata S, Nagamatsu H, Yamada T. TUR-P stress urinary incontinence successfully treated by periurethral injection of autologous fat to the prostate: a case report.  Hinyokika Kiyo. 1995;  41 553-556
• 37 Barranger E, Fritel X, Olivier K, Liou Y, Pigne A. Results of transurethral injection of silicone microimplants for females with intrinsic sphincter deficiency.  J Urol. 2000;  164 1619-1622
• 38 Currie L, Drutz H P, Oxorn D. Adipose tissue and lipid drop embolism following periurethral injection of autologous fat: case report and review of the literature.  Int Urogynecol J Pelvic Floor Dysfunct. 1997;  8 923-926
• 39 Sweat S D, Lightner D J. Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents.  J Urol. 1999;  161 93-96
• 40 Leonhard M P, Canning D A, Epstein J I, Gearhart J P, Jeffs R D. Local tissue reaction to the subureteral injection of glutaraldehyde crosslinked bovine collagen in humans.  J Urol. 1990;  143 1209-1212
• 41 Griebling T L, Kreder Jr K J, Williams R D. Transurethral collagen injection for treatment of post-prostatectomy urinary incontinence in men.  Urology. 1997;  49 907-912
• 42 Faerber G J. Endoscopic collagen injection therapy in elderly women with type I stress urinary incontinence.  J Urol. 1996;  155 512-514
• 43 Goldenberg S L, Marketin M J. Periurethral collagen injections for patients with stress incontinence.  J Urol. 1994;  151 479A
• 44 Herschorn S, Radomski S B, Steele D J. Early experience with intraurethral collagen injection for urinary incontinence.  J Urol. 1992;  148 1797-1800
• 45 Herschorn S, Steele D J, Radomski S B. Follow-up of intraurethral collagen for female stress urinary incontinence.  J Urol. 1996;  156 1305-1309
• 46 Khullar V, Cardozo L D, Abbott D, Anders K. GAX collagen in the treatment of urinary incontinence in elderly women: a two year follow up.  BJOG. 1997;  104 96-99
• 47 Kieswetter H, Fischer M, Wober L, Flamm J. Endoscopic implantation of collagen (GAX) for the treatment of urinary incontinence.  Br J Urol. 1992;  69 22-25
• 48 Monga A K, Robinson D, Stanton S L. Periurethral collagen injections for genuine stress incontinence: a 2 year follow-up.  Br J Urol. 1995;  76 156-160
• 49 Moore K N, Chetner M P, Metcalfe J B, Griffith D J. Periurethral implantation of glutaraldehyde cross-linked collagen (Contigen) in women with type I or III stress incontinence: quantitative outcome measures.  Br J Urol. 1995;  75 359-363
• 50 O'Connell H E, McGuire E J, Aboseif S, Usui A. Transurethral collagen therapy in women.  J Urol. 1995;  154 1463-1465
• 51 Winters J C, Appel R. Periurethral injection of collagen in the treatment of intrinsic sphincteric deficiency in the female patient.  Urol Clin North Am. 1995;  22 673-678
• 52 Steele A C, Kohli N, Karram M M. Periurethral collagen injection for stress incontinence with and without urethral hypermobility.  Obstet Gynecol. 2000;  95 327-331
• 53 Corcos J, Fournier C. Periurethral collagen injection of female stress urinary incontinence: 4-year follow-up results.  Urology. 1999;  54 815-818
• 54 Gorton E, Stanton S, Monga A, Wiskind A K, Lentz G M, Bland D R. Periurethral collagen injection: a long term follow-up study.  BJU Int. 1999;  84 966-971
• 55 Richardson T D, Kenelly M J, Faerber G J. Endoscopical injection of glutaraldehyde cross-linked collagen for the treatment of intrinsic sphincter deficiency in women.  Urology. 1995;  46 378-381
• 56 Gottfried H W, Maier S, Gschwend J, Brandle E, Hautmann R E. Minimal invasive Behandlung der Stressharninkontinenz durch Kollagenapplikation. Vergleich zwischen endosonographisch gezielter und transurethraler submuköser Kollageninjektion.  Urologe A. 1996;  35 6-10
• 57 Stothers L, Goldenberg S L, Leone E F. Complications of periurethral collagen injection for stress urinary incontinence.  J Urol. 1998;  159 806-907
• 58 Aboseif S R, O'¿Connell H E, Usul A, McGuire E J. Collagen injection for intrinsic sphincteric deficiency in men.  J Urol. 1996;  155 10-13
• 59 Martins F E, Benett C J, Dunn M, Filho D, Keller T, Lieskovsky G. Adverse prognostic factors for urinary incontinence following radical retropubic prostatectomy.  J Urol. 1997;  158 1745-1749
• 60 Nataluk E A, Assimos D G, Kroonvand R L. Collagen injections for treatment of urinary incontinence secondary to intrinsic sphincter deficiency.  J Endourol. 1995;  9 403-406
• 61 Smith D N, Appell R A, Rackley R R, Winters J C. Collagen injection for post-prostatectomy incontinence.  J Urol. 1998;  160 364-367
• 62 Tiguert R, Gheiler E L, Gudziak M R. Collagen injection in the management of post-radical prostatectomy intrinsic sphincteric deficiency.  Neurourol Urodyn. 1999;  18 653-658
• 63 Kageyama S, Kazuki K, Suzuki K, Ushiyama T, Susuki T, Aso Y. Collagen implantation for post-prostatectomy incontinence: early experience with a transrectal ultrasonography guided method.  J Urol. 1994;  152 1473
• 64 Klutke C G, Tiemann D D, Nadler R B, Andriole G L. Antegrade collagen injection for stress urinary incontinence after radical prostatectomy: technique and early results.  J Endourol. 1996;  10 279-282
• 65 Klutke J J, Chhikara S, Andriole G, Klutke C G. Long-term results after antegrade collagen injection for stress urinary incontinence following radical retropubic prostatectomy.  Urology. 1999;  53 974-977
• 66 Loughlin K R, Comiter C V. New technique for antegrade collagen injection for post-radical prostatectomy stress urinary incontinence.  Urology. 1999;  53 410-411
• 67 Chaliha C, Williams G. Periurethral injection for the treatment of urinary incontinence.  Br J Urol. 1995;  76 151-155
• 68 Colombo T, Augustin H, Breinl E, Schips L, Hubmer G. The use of polymethylsiloxane in the treatment of incontinence after radical prostatectomy.  Br J Urol. 1997;  80 923-926
• 69 Solomon L Z, Birch B R, Cooper A J, Davies C L, Holmes S AV. Nonhomologous bioinjectable materials in urology: `size matters`?.  BJU International. 2000;  85 641-645
• 70 Buckley J F, Lingham K, Lloyd S N, Meddings R, Scott R, Kirk D, Deane R, Kyle K. Injectable silicone macroparticles for female urinary incontinence.  J Urol. 1993;  149 402A (abstract 759)
• 71 Edhem I, Shah N, Nathan S, Foley S J, Shah J R. Endoscopic correction of intractable stress incontinence with Macroplastique: long term results. XIIIth Congress of the European Association of Urology. Barcelona, Spain 1998
• 72 Henalla S M, Hall V, Duckett J RA, Link C, Usman F, Tromans P M, van Veggel L. A multicentre evaluation of a new surgical technique for urethral bulking in the treatment of genuine stress incontinence.  BJOG. 2000;  107 1035-10 39
• 73 Hidar S, Attayaoui F, de Leval J. Injection periurethrale de micro particules de silicone dans le traitement de l'incontinence urinaire par insuffisance sphinctérienne (Periurethral injection of silicone microimplants in the treatment of urinary incontinence due to sphincter insufficiency).  Prog Urol. 2000;  10 219-223
• 74 Koelbl K, Saz V, Dorfler D, Hausler G, Sam C, Hanzal E. Transurethral injection of silicone microimplants for intrinsic urethral sphincter deficiency.  Obstet Gynecol. 1998;  92 332-336
• 75 Salvatore S, Scalambrino S. Gallazzi S, Vignali M, Milani R. Macroplastique injection in women with intrinsic sphincter deficiency. 30th Annual Meeting of the International Continence Society. Tampere, Finnland 2000
• 76 Sheriff M K, Foley S, Mcfarlane J, Nauth-Misir R, Shah P J. Endoscopic correction of intractable stress incontinence with silicone micro-implants.  Eur Urol. 1997;  32 284-288
• 77 Usman F, Henalla S. A single transurethral Macroplastique injection as primary treatment for stress incontinence in women.  J Obstet Gynecol. 1998;  18 56-60
• 78 Adile B, Gugliotta G, Caputo A, Lo Bue A. Macroplastique for the treatment of type III stress urinary incontinence: 2 year follow-up. 26th Annual Meeting of the International Continence Society. Athens, Greece 1996
• 79 Fisher M, Dimou G. Endoscopic implantation of Macroplastique silicone for the treatment of female urinary incontinence. 27th Annual Meeting of the International Continence Society. Yokohama, Japan 1997
• 80 Bugel H, Pfister C, Sibert L, Cappele O, Khalaf A, Grise P. Les injections intra-urethrales de Macro Plastique dans le traitement de l'incontinence urinaire apres chirurgie prostatique (Intraurethral Macroplastique injections in the treatment of urinary incontinence after prostatic surgery).  Prog Urol. 1999;  9 1068-1076
• 81 Khastgir J N, Shah P JR. Macroplastique injections: How effective is it for stress incontinence in males? 30th Annual Meeting of the International Continence Society. Tampere, Finnland 2000
• 82 Strasser H, Stenzel A, Bartsch G. Intraurethral Macroplastique injections in treatment of urinary stress incontinence.  Eur Urol. 1999;  35 (Suppl 2) 114
• 83 Taino H, Kylmälä T, Tammela T LJ. Treatment of postoperative male urinary incontinence using transurethral Macroplastique injections. 30th Annual Meeting of the International Continence Society. Tampere, Finnland 2000
• 84 Furness III P D, Kolligan M E, Lang S J, Kaplan W E, Kropp B P, Cheng E Y. Injectable small intestinal submucosa: Preliminary evaluation for use in endoscopic urological surgery.  J Urol. 2000;  164 1680-1686
• 85 Ford C N, Staskowski P A, Bless D M. Autologous collagen vocal fold injection: a preliminary clinical study.  Laryngoscope. 1995;  105 944-948
• 86 Cendrom M, DeVore D P, Conolly R, Sant G R, Ucci A, Calahan R, Klauber G T. The biological behaviour of autologous collagen injected into the rabbit bladder.  J Urol. 1995;  154 808-811
• 87 Atala A, Kim W, Paige K T, Vacanti J P, Retik A B. Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension.  J Urol. 1994;  152 641-643
• 88 Bent A E, Tutrone R F, Lloyd K, Badlani G, Kennelly M J. Treatment of intrinsic sphincter deficiency using autologous ear cartilage as a periurethral bulking agent.  J Urol. 2000;  163 75 (abstract 332A)
• 89 Atala A, Freeman M R, Vacanti J P, Shepard J, Retik A B. Implantation in vivo and retrival of artificial structures consisting of rabbit and human urothelium and human bladder muscle.  J Urol. 1993;  150 608-612
• 90 Yokoyama T, Yoshimura N, Dhir R, Qu Z, Fraser M O, Kumon H, de Groat W C, Huard J, Chancellor M B. Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence.  J Urol. 2001;  165 271-276
• 91 Huard J, Yokoyama T, Lavelle J, Teahan S, Watanabe T, Ozawa H, Yoshimura N, de Groat W C, Qu Z, Chancellor M B, McHugh K. Differentiation of primary myoblast injection into the lower urinary tract; creation of detrusor cellular myoplasty.  J Urol. 1999;  161 66 (abstract 248)
• 92 Walker R S, Wilson K, Clark A E. Injectable bioglass as a potential substitute for injectable polytetrafluoroethylene.  J Urol. 1992;  148 645-647
• 93 Wilson J, Noletti D. (Eds) .Handbook of Bioactive Ceramics, Bioactive Glasses and Glass Ceramics. Boca Raton, FL: CRC Press 1990 1: 283-300
• 94 Ridgefield N J. Formal Report of feasibility study of Hylagel® Uro. Biomatrix Corporation June 2000
• 95 Stenberg A, Larsson G, Johnson P, Heimer G, Ulmsten U. DiHa Dextran Copolymer, a new biocompatible material for endoscopic treatment of stress incontinent women.  Acta Obstet Gynecol Scand. 1999;  78 436-442
• 96 Lylyk P, Vinuela F, Vinters H V, Dion J, Bentson J, Duckwiller G, Lin T. Use of a new mixture for embolisation of intracranial vascular malformations: preliminary experimental experience.  Neuroradiology. 1990;  32 304-309
• 97 Merguerian P A, McLorie G A, Khoury A E, Thorner P, Churchill B M. Submucosal injection of polyvinyl alcohol foam in rabbit bladder.  J Urol. 1990;  144 531-533
• 98 Lightner D, Diokono A, Snyder J, Calvosa C, Khan A, Andersen R, Gilberto Brito C, MacDonald J, Killion D, Saltzstein D, Rochester M N. Study of Duraspere® in the treatment of stress urinary incontinence: a multicenter, double blind randomised, comparative study.  J Urol. 2000;  163 166 (abstract 739)
• 99 Pycha A, Klingler C H, Haitel A, Heinz-Peer G, Marberger M. Implantable microballons: an attractive alternative in the management of intrinsic sphincter deficiency.  Eur Urol. 1998;  33 469-475